|
TTC37 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.79709999999345E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.806400E-02 |
| Normal-vs-Stage2 |
1.247850E-01 |
| Normal-vs-Stage3 |
1.184399999965E-06 |
| Normal-vs-Stage4 |
3.00680000009379E-07 |
| Stage1-vs-Stage2 |
6.551000E-01 |
| Stage1-vs-Stage3 |
1.036090E-03 |
| Stage1-vs-Stage4 |
3.552300E-04 |
| Stage2-vs-Stage3 |
7.443600E-02 |
| Stage2-vs-Stage4 |
2.842400E-02 |
| Stage3-vs-Stage4 |
5.127600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.377600E-04 |
| Normal-vs-AfricanAmerican |
2.48069999999601E-05 |
| Normal-vs-Asian |
1.564180E-01 |
| Caucasian-vs-AfricanAmerican |
6.824400E-02 |
| Caucasian-vs-Asian |
9.723400E-01 |
| AfricanAmerican-vs-Asian |
4.412000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66208999999862E-05 |
| Normal-vs-Female |
1.489590E-02 |
| Male-vs-Female |
1.085420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.994700E-04 |
| Normal-vs-Age(41-60Yrs) |
2.077400E-03 |
| Normal-vs-Age(61-80Yrs) |
3.642900E-04 |
| Normal-vs-Age(81-100Yrs) |
3.107600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.258100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.086200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.774200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.854400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.472600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.261800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.130600E-01 |
| Normal-vs-Grade 2 |
9.784000E-02 |
| Normal-vs-Grade 3 |
2.03759999999331E-05 |
| Normal-vs-Grade 4 |
1.65790003947563E-09 |
| Grade 1-vs-Grade 2 |
3.555400E-01 |
| Grade 1-vs-Grade 3 |
4.827600E-02 |
| Grade 1-vs-Grade 4 |
7.761300E-04 |
| Grade 2-vs-Grade 3 |
6.081000E-03 |
| Grade 2-vs-Grade 4 |
1.92070000004652E-06 |
| Grade 3-vs-Grade 4 |
5.340700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.845200E-01 |
| Normal-vs-ccB subtype |
7.33349999615385E-08 |
| ccA subtype-vs-ccB subtype |
1.3679000043787E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.048600E-04 |
| Normal-vs-N1 |
2.353500E-02 |
| N0-vs-N1 |
1.360350E-01 |
|
|
